Since then, it has affected more than 253 million patients worldwide, causing more than 4 million deaths. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) rapidly evolved into a global pandemic. The previous infection with SARS‐CoV‐2 boosted immune response after receiving the first vaccination (roughly 30 times higher than those without previous infection) nonetheless, after the second dose, the immune response did not show a higher titre as might be expected. No serious adverse effects due to vaccination were reported nonetheless, non‐medical HCWs reported more side effects after the second dose. Blood samples were obtained for serology testing after the first and second doses of vaccine. All participants were scheduled for their two doses of mRNA BNT162b2 vaccine and provided information through a questionnaire: demographic characteristics, antibody serum titres and vaccination‐related side effects.

This is a case series study analysing humoral immune response and vaccination side effects after two doses of a BNT162b2 mRNA among healthcare workers (HCWs) in Mexico. The antibody response to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) as well as the host immune response after vaccination and viral infection have shown to be highly heterogeneous.

Yareth Demo free